Brief: Jakob Lindberg Is Appointed CEO Of Oncopeptides

Oncopeptides AB

15/11/2021 07:43

Nov 15 (Reuters) - Oncopeptides AB  ONCO.ST :
    * JAKOB LINDBERG APPOINTED CEO OF ONCOPEPTIDES
    * HAS APPOINTED JAKOB LINDBERG AS CHIEF EXECUTIVE OFFICER,
CEO OF
ONCOPEPTIDES
    * JAKOB LINDBERG REPLACES MARTY J DUVALL, WHO HAS BEEN CEO
SINCE
JULY 1, 2020. THESE CHANGES ARE EFFECTIVE IMMEDIATELY.
    * JAKOB LINDBERG WAS CEO OF ONCOPEPTIDES FROM RESTART OF
COMPANY
IN 2011, UNTIL JUNE 2020.
    * ONCOPEPTIDES HEREBY ALSO ANNOUNCES THAT A NEW STRATEGY AND
PLAN
FORWARD WILL BE PRESENTED AND ARTICULATED DURING Q1 2022.

Source text for Eikon:  ID:nWkr6PqpxM 
Further company coverage:  ONCO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))